VEGF-R1/Flt-1 Receptor as a Characteristic of the Angiogenic Phenotype of Uveal Melanoma

Thanks to new fundamental data, our understanding of the angiogenesis’ role and its molecular participants has changed. Molecular genetic mechanisms of activation of signaling pathways of proliferation, malignancy, suppression of the tumor cells’ apoptosis, carried out through the interaction of the VEGF molecule with its receptors, have been deciphered. Molecular genetic mechanisms of activation of signaling pathways of proliferation, malignancy, suppression of apoptosis of tumor cells, carried out through the interaction of the VEGF molecule with its receptors, have been deciphered. The doctrine of angiogenesis has changed. Angiogenesis began to be considered in the aspect of the increasing anaplasia mechanism, accelerating proliferation, the formation of a clone of stem tumor cells, highly resistant to chemotherapy and radiation therapy with a high potential for metastasis. It is time to reconsider the role of individual biological markers of angiogenesis in their suitability in predicting disease outcome and evaluating them as a potential target for targeted therapy. In this aspect, uveal melanoma (UM) as a model of an extremely aggressive malignant tumor using its angiogenic phenotype to accelerate hematogenous metastasis is of particular interest. One of the characteristics of the angiogenic phenotype is VEGF-R1/Flt-1. The purpose: to study the expression of the VEGF-R1/Flt-1 receptor as a characteristic of the angiogenic phenotype of UM in correlation with its clinical and morphological indicators and the outcome of the disease. The authors conducted a retrospective study on 98 archival paraffin blocks of the eyes of patients with UM. The following general patterns of Flt expression in UM cells are revealed: Basic expression takes place in the smallest tumor proliferates UM (T1). Moreover, overexpression (IGH-gradation III) of Flt in the nucleus (39.7 %) and cytoplasm (36.3 %) occurred in every third patient with UM in stage T1. The peak of reception for the maximum average percentage of positive cells and the average cellular IGH gradation of expression was recorded at the T2 stage, after which there was a slow decline to the T4 stage. The number of overexpressive Flt in the nucleus and cytoplasm of UM cells increased x 2 times (75.3 %) to the T2 stage. The peak of Flt nuclear expression in terms of the number of immunopositive cells was also recorded at the T2 stage. The authors concluded that VEGF-R1/Flt-1 expression is a very important characteristic of the UM angiogenic phenotype. In the vast majority of UM, there is an expression of the VEGF-R1/Flt-1 receptor in the nucleus and cytoplasm of tumor cells. The revealed correlations of VEGF-R1/Flt-1 expression with the volume and histological type of tumor, disease stage and metastasis allow them to consider Flt-1 an important indicator associated with the pathogenesis and prognosis of uveal melanoma and a potential target for targeted therapy. A prognostic adverse factor in the aspect of the prognosis of the risk of metastases should be considered the index of the ratio Flt C/Flt N ≥ 3.

1. Karamysheva A.F. Tumor angiogenesis: mechanisms, new approaches. In the book: Carcinogenesis. Ed. by D.G. Zaridze. Moscow: Scientific World: 2000 (In Russ.).

2. Holmes K., Roberts O.L., Thomas A.M., Cross M.J. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal. journal. 2007;19(10):2003–2012. DOI: 10.1016/j.cellsig.2007.05.013

3. Stuttfeld E., Ballmer-Hofer K. Structure and function of VEGF receptors. IUBMB Life. 2009;61(9):915–922. DOI: 10.1002/iub.234

4. Gabrilove J.L. Angiogenic growth factors: Autocrine and paracrine regulation of survival in hematologic malignancies. Oncologist. 2001;6(Suppl. S5):4–7. DOI: 10.1634/theoncologist.6-suppl_5-4

5. Li B., Xiu R. Angiogenesis: From molecular mechanisms to translational implications. Clin. Hemorheol. Microcirc. 2013;54(4):345–355. DOI: 10.3233/CH-121647

6. Cébe-Suarez S., Zehnder-Fjällman A., Ballmer-Hofer K. The role of VEGF receptors in angiogenesis; complex partnerships Cell Mol Life Sci. 2006;63(5):601–615. DOI: 10.1007/s00018-005-5426-3

7. Dvorak A.M., Feng D. The vesiculo-vacuolar organelle: a new endothelial cell permeability organelle. J. Histochem. Cytochem. 2001;49(4):419–432. DOI: 10.1177/002215540104900401

8. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 1998;140(4):947–959. DOI: 10.1083/jcb.140.4.947

9. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 1995;108(Pt 6):2369–2379.

10. Hanks S.K., Quinn A.M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 1988;241(4861):42–52. DOI: 10.1126/science.3291115

11. Dengjel J., Kratchmarova I., Blagoev B. Receptor tyrosine kinase signaling: a view from quantitative proteomics. Mol Biosyst. 2009;5(10):1112–1121. DOI: 10.1039/ b909534a

12. Hoeben A., Landuyt B., Highley M.S., Wildiers H., Van Oosterom A.T., De Bruijn E.A. Vascular Endothelial Growth Factor and Angiogenesis Pharmacological Reviews. 2004;56(4):549–580. DOI: 10.1124/pr.56.4.3

13. Garg G., Finger P.T., Kivelä T.T., Simpson E.R., Gallie B.L., Saakyan S. Patients presenting with metastases: stage IV uveal melanoma, an international study..Br J Ophthalmol. 2021;0:1–8. DOI: 10.1136/bjophthalmol-2020-317949

14. Brierley J., Gospodarowicz M.K., Wittekind C. (eds.) TNM classification of malignant tumours, Eighth edition edn. Oxford, UK; Hoboken, NJ: John Wiley & Sons, Inc; 2017. 272 p. ISBN: 978-1-119-26357-9

15. Heegaard S., Jensen O.A., Prause J.U. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45. Melanoma Res. 2000;10(4):350–354. DOI: 10.1097/00008390-200008000-00006

16. Dabbs D.J. Diagnostic immunohistochemistry. 5th Ed. Churchill Livingstone, Philadelphia. 2002. 641 p. ISBN: 9780323551601

17. Fan F., Wey J.S., McCarty M.F., Belcheva A., Liu W. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene. 2005;24(16):2647–2653. DOI: 10.1038/sj.onc.1208246

18. Vincent L. Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells. Cancer Res. 2005;65(8):3185–3192. DOI: 10.1158/0008-5472.CAN-04-3598

19. Tyrsina E.G. VEGF-R1 as a potential molecular target for anticancer therapy. Reports of the Academy of Sciences. (Biochemistry, biophysics, molecular biology) = Doklady Akademii Nauk. Biohimiya, biofizika, molekulyarnaya biologiya. 2018;478(2):236–239 (In Russ.).

20. Lee T.H. Vascular Endothelial Growth Factor Mediates Intracrine Survival in Human Breast Carcinoma Cells through Internally Expressed VEGFR1/FLT1. PLoS Med. 2007;4(6):1001–1016. DOI: 10.1371/journal.pmed.0040186

21. Van Limbergen E.J., Zabrocki P., Porcu M., Hauben E., Cools J., Nuyts S. FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma. Acta Oncol. 2004;53(5):637–645. DOI: 10.3109/0284186X.2013.835493

22. Bhattacharya R., Xiang-Cang Ye, Rui Wang, Xia Ling, McManus M., Fan Fan, et al. Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. Cancer Res. 2016;76(10):3014–3024. DOI: 10.1158/00085472.CAN-15-1605

23. Tran J., Rak J., Sheehan C., Saibil S.D., LaCasse E., Korneluk R.G. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1999;264:781–788. DOI: 10.1006/bbrc.1999.1589

24. Wey J.S., Fan F., Gray M.J., Bauer T.W., McCarty M.F., Somcio R. Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines Cancer. 2005;104(2):427–438. DOI: 10.1002/cncr.21145

25. Owen L.A., Uehara H., Cahoon J. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. PLoS One. 2012;7(3):e33576. DOI: 10.1371/journal.pone.0033576